CAVEN Fundamental Analysis - CAVENDISH HYDROGEN ASA

Name: CAVENDISH HYDROGEN ASA (CAVEN) Stock
Brand: CAVENDISH HYDROGEN ASA
Rating: 4.5 (3 reviews)

Fundamental Rating

CAVEN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 57 industry peers in the Electrical Equipment industry. CAVEN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, CAVEN is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CAVEN has reported negative net income.

In the past year CAVEN has reported a negative cash flow from operations.

1.2 Ratios

With a Return On Assets value of -30.39%, CAVEN is not doing good in the industry: 89.47% of the companies in the same industry are doing better.

CAVEN has a worse Return On Equity (-39.05%) than 80.70% of its industry peers.

		Industry Rank	Sector Rank
ROA	-30.39%
ROE	-39.05%
ROIC	N/A

ROA(3y)-52.26%

ROA(5y)N/A

ROE(3y)-492.28%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 51.89%, CAVEN belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.

CAVEN's Gross Margin has improved in the last couple of years.

CAVEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	51.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y20.15%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CAVEN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CAVEN remains at a similar level compared to 1 year ago.

CAVEN has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.06, we must say that CAVEN is in the distress zone and has some risk of bankruptcy.

CAVEN has a Altman-Z score of 0.06. This is in the lower half of the industry: CAVEN underperforms 75.44% of its industry peers.

CAVEN has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.

CAVEN's Debt to Equity ratio of 0.03 is amongst the best of the industry. CAVEN outperforms 92.98% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	0.06

ROIC/WACCN/A

WACC8.31%

2.3 Liquidity

A Current Ratio of 4.04 indicates that CAVEN has no problem at all paying its short term obligations.

With an excellent Current ratio value of 4.04, CAVEN belongs to the best of the industry, outperforming 92.98% of the companies in the same industry.

CAVEN has a Quick Ratio of 2.84. This indicates that CAVEN is financially healthy and has no problem in meeting its short term obligations.

CAVEN has a Quick ratio of 2.84. This is amongst the best in the industry. CAVEN outperforms 94.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.04
Quick Ratio	2.84

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.21% over the past year.

The Revenue has been growing slightly by 7.34% in the past year.

CAVEN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.23% yearly.

EPS 1Y (TTM)21.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%36.71%

Revenue 1Y (TTM)7.34%

Revenue growth 3Y-0.23%

Revenue growth 5YN/A

Sales Q2Q%-39.13%

3.2 Future

CAVEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.53% yearly.

Based on estimates for the next years, CAVEN will show a very strong growth in Revenue. The Revenue will grow by 41.42% on average per year.

EPS Next Y1.45%

EPS Next 2Y24.53%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year25.93%

Revenue Next 2Y41.42%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

CAVEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CAVEN. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

CAVEN's earnings are expected to grow with 24.53% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.53%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CAVEN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CAVENDISH HYDROGEN ASA

OSL:CAVEN (11/5/2025, 3:58:27 PM)

8.69

+0.32 (+3.82%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)N/A N/A

Earnings (Next)11-13 2025-11-13

Inst Owners4.87%

Inst Owner ChangeN/A

Ins Owners0.18%

Ins Owner ChangeN/A

Market Cap292.16M

Revenue(TTM)21.41M

Net Income(TTM)-23159000

Analysts86.67

Price Target9.95 (14.5%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-43.57%

Min Revenue beat(2)-55.1%

Max Revenue beat(2)-32.04%

Revenue beat(4)0

Avg Revenue beat(4)-35.05%

Min Revenue beat(4)-55.1%

Max Revenue beat(4)-22.25%

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-55.68%

PT rev (3m)-39.06%

EPS NQ rev (1m)6.25%

EPS NQ rev (3m)6.25%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)-33.33%

Revenue NQ rev (3m)-33.33%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.16
P/FCF	N/A
P/OCF	N/A
P/B	0.42
P/tB	0.53
EV/EBITDA	N/A

EPS(TTM)-8.08

EYN/A

EPS(NY)-3.74

Fwd EYN/A

FCF(TTM)-8.11

FCFYN/A

OCF(TTM)-6.11

OCFYN/A

SpS7.47

BVpS20.68

TBVpS16.25

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-30.39%
ROE	-39.05%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	51.89%
FCFM	N/A

ROA(3y)-52.26%

ROA(5y)N/A

ROE(3y)-492.28%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y20.15%

GM growth 5YN/A

F-Score4

Asset Turnover0.28

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	129.55%
Cap/Sales	26.77%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.04
Quick Ratio	2.84
Altman-Z	0.06

F-Score4

WACC8.31%

ROIC/WACCN/A

Cap/Depr(3y)90.97%

Cap/Depr(5y)N/A

Cap/Sales(3y)21.26%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)21.21%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%36.71%

EPS Next Y1.45%

EPS Next 2Y24.53%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)7.34%

Revenue growth 3Y-0.23%

Revenue growth 5YN/A

Sales Q2Q%-39.13%

Revenue Next Year25.93%

Revenue Next 2Y41.42%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y1.9%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-448.44%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-37.99%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-27.78%

OCF growth 3YN/A

OCF growth 5YN/A

CAVENDISH HYDROGEN ASA / CAVEN.OL FAQ

Can you provide the ChartMill fundamental rating for CAVENDISH HYDROGEN ASA?

ChartMill assigns a fundamental rating of 3 / 10 to CAVEN.OL.

Can you provide the valuation status for CAVENDISH HYDROGEN ASA?

ChartMill assigns a valuation rating of 1 / 10 to CAVENDISH HYDROGEN ASA (CAVEN.OL). This can be considered as Overvalued.

Can you provide the profitability details for CAVENDISH HYDROGEN ASA?

CAVENDISH HYDROGEN ASA (CAVEN.OL) has a profitability rating of 1 / 10.

What is the expected EPS growth for CAVENDISH HYDROGEN ASA (CAVEN.OL) stock?

The Earnings per Share (EPS) of CAVENDISH HYDROGEN ASA (CAVEN.OL) is expected to grow by 1.45% in the next year.

CAVENDISH HYDROGEN ASA (CAVEN.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CAVENDISH HYDROGEN ASA / CAVEN.OL FAQ

Can you provide the ChartMill fundamental rating for CAVENDISH HYDROGEN ASA?

Can you provide the valuation status for CAVENDISH HYDROGEN ASA?

Can you provide the profitability details for CAVENDISH HYDROGEN ASA?

What is the expected EPS growth for CAVENDISH HYDROGEN ASA (CAVEN.OL) stock?